Open AccessCommercial Disinfectants During Disinfection Process Validation: More Failures than Success
Author(s) -
Shiv Sekhar Chatterjee,
Sushil Kumar Chumber,
Uma Khanduri
Publication year - 2016
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2016/20290.8363
Subject(s) - disinfectant , bacillus cereus , pseudomonas aeruginosa , microbiology and biotechnology , medicine , mycobacterium fortuitum , staphylococcus aureus , bacteria , biology , mycobacterium , genetics , pathology
Disinfection process validation is mandatory before introduction of a new disinfectant in hospital services. Commercial disinfection brands often question existing hospital policy claiming greater efficacy and lack of toxicity of their products. Inadvertent inadequate disinfection leads to morbidity, patient's economic burden, and the risk of mortality.